NVS260116P00092500 Option on Novartis AG ADR

NVS Stock  USD 98.59  0.58  0.58%   

Novartis Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Novartis Market Cap Over Time

   Market Cap   
       Timeline  

Novartis Total Stockholder Equity

Total Stockholder Equity

57.16 Billion

At this time, Novartis' Total Stockholder Equity is comparatively stable compared to the past year.

Novartis Corporate Directors

Ton BuechnerNon-Executive Independent DirectorProfile
Frans HoutenNon-Executive Independent DirectorProfile
Nancy AndrewsNon-Executive Independent DirectorProfile
Elizabeth DohertyNon-Executive Independent DirectorProfile

Additional Tools for Novartis Stock Analysis

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.